- Home
- BNED vs ABSI Comparison
BNED vs ABSI Comparison
Compare BNED & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNED | ABSI |
|---|---|---|
| Founded | 1965 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.5M | 997.8M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BNED | ABSI |
|---|---|---|
| Price | $10.55 | $8.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.96 |
| AVG Volume (30 Days) | 285.1K | ★ 2.6M |
| Earning Date | 03-10-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 119.60 | 10.64 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,714,770,000.00 | $4,534,000.00 |
| Revenue This Year | N/A | $215.96 |
| Revenue Next Year | N/A | $319.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.50 | N/A |
| 52 Week Low | $5.90 | $2.24 |
| 52 Week High | $14.75 | $12.06 |
Technical Indicators
Market Signals| Indicator | BNED | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 35.61 | 39.27 |
| Support Level | $10.50 | $6.69 |
| Resistance Level | $11.07 | $10.03 |
| Average True Range (ATR) | 0.59 | 0.49 |
| MACD | -0.16 | -0.13 |
| Stochastic Oscillator | 2.30 | 6.96 |
Price Performance
Historical ComparisonAbout BNED Barnes & Noble Education Inc
Barnes & Noble Education Inc is a contract operator of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States. The company is also a textbook wholesaler and inventory management hardware and software provider. It offers course materials through physical and online bookstores, including new and used print textbooks, rental options, digital textbooks, and publisher-hosted digital courseware. Products are also offered directly to students through Textbooks.com. The majority of the company's revenue is derived from the sale of products through its bookstore locations, including virtual bookstores, and the bookstore affiliated e-commerce websites.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.